Literature DB >> 29715085

Chemerin in a Mouse Model of Non-alcoholic Steatohepatitis and Hepatocarcinogenesis.

Elisabeth M Haberl1, Rebekka Pohl1, Lisa Rein-Fischboeck1, Susanne Feder1, Christopher J Sinal2, Christa Buechler3.   

Abstract

BACKGROUND/AIM: Non-alcoholic steatohepatitis (NASH) is a risk factor for hepatocellular carcinoma (HCC). The adipokine chemerin protects from HCC and is reduced in human HCC. In this study, chemerin expression was analyzed in a murine model of NASH-HCC.
MATERIALS AND METHODS: Serum and hepatic chemerin, and ex vivo chemerin receptor activation were monitored in NASH and NASH-HCC in mice fed a low-methionine diet deficient in choline after initiation of tumors by injection of diethylnitrosamine.
RESULTS: In non-tumorous liver tissues, the extent of hepatic steatosis, and the levels of proteins regulating hepatic lipids and liver fibrosis were similar in NASH and NASH-associated HCC. Systemic and hepatic chemerin, and chemerin receptor activation were not changed in HCC. Liver tumors only developed in diethylnitrosamine-injected mice and their number was increased in NASH. Chemerin protein was induced in liver in NASH, but was unchanged in HCC tissues.
CONCLUSION: Hepatic and serum chemerin and ex vivo analyzed chemerin receptor activation do not differ in murine NASH-associated HCC when compared to NASH. Hepatic tumors still develop despite high endogenous levels of serum and liver chemerin protein. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  CMKLR1; Liver tumor; NASH; chemerin activity

Mesh:

Substances:

Year:  2018        PMID: 29715085     DOI: 10.21873/anticanres.12507

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

Review 1.  More Than an Adipokine: The Complex Roles of Chemerin Signaling in Cancer.

Authors:  Kerry B Goralski; Ashley E Jackson; Brendan T McKeown; Christopher J Sinal
Journal:  Int J Mol Sci       Date:  2019-09-26       Impact factor: 5.923

2.  Hepatic lipid profile in mice fed a choline-deficient, low-methionine diet resembles human non-alcoholic fatty liver disease.

Authors:  Elisabeth M Haberl; Rebekka Pohl; Lisa Rein-Fischboeck; Marcus Höring; Sabrina Krautbauer; Gerhard Liebisch; Christa Buechler
Journal:  Lipids Health Dis       Date:  2020-12-09       Impact factor: 3.876

3.  Accumulation of cholesterol, triglycerides and ceramides in hepatocellular carcinomas of diethylnitrosamine injected mice.

Authors:  Elisabeth M Haberl; Rebekka Pohl; Lisa Rein-Fischboeck; Marcus Höring; Sabrina Krautbauer; Gerhard Liebisch; Christa Buechler
Journal:  Lipids Health Dis       Date:  2021-10-10       Impact factor: 3.876

Review 4.  Circulating chemerin levels in metabolic-associated fatty liver disease: a systematic review and meta-analysis.

Authors:  Qian Ren; Hongya Wang; Yan Zeng; Xia Fang; Mei Wang; Dongze Li; Wei Huang; Yong Xu
Journal:  Lipids Health Dis       Date:  2022-03-02       Impact factor: 3.876

5.  Hepatocyte expressed chemerin-156 does not protect from experimental non-alcoholic steatohepatitis.

Authors:  Rebekka Pohl; Laura Eichelberger; Susanne Feder; Elisabeth M Haberl; Lisa Rein-Fischboeck; Nichole McMullen; Christopher J Sinal; Astrid Bruckmann; Thomas S Weiss; Michael Beck; Marcus Höring; Sabrina Krautbauer; Gerhard Liebisch; Reiner Wiest; Josef Wanninger; Christa Buechler
Journal:  Mol Cell Biochem       Date:  2022-04-21       Impact factor: 3.842

6.  Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular Carcinoma.

Authors:  Elisabeth M Haberl; Rebekka Pohl; Lisa Rein-Fischboeck; Susanne Feder; Christopher J Sinal; Astrid Bruckmann; Marcus Hoering; Sabrina Krautbauer; Gerhard Liebisch; Christa Buechler
Journal:  Int J Mol Sci       Date:  2019-12-30       Impact factor: 5.923

7.  Chemerin Overexpression in the Liver Protects against Inflammation in Experimental Non-Alcoholic Steatohepatitis.

Authors:  Rebekka Pohl; Susanne Feder; Elisabeth M Haberl; Lisa Rein-Fischboeck; Thomas S Weiss; Marlen Spirk; Astrid Bruckmann; Nichole McMullen; Christopher J Sinal; Christa Buechler
Journal:  Biomedicines       Date:  2022-01-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.